Published in Arch Ophthalmol on November 01, 2006
African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes. Arch Ophthalmol (2010) 1.89
Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol (2009) 1.70
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology (2009) 1.47
An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol (2011) 1.46
Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci (2011) 1.23
Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol (2009) 1.21
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials. Br J Ophthalmol (2008) 1.13
The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology (2013) 1.07
Difficulty with out-loud and silent reading in glaucoma. Invest Ophthalmol Vis Sci (2013) 1.07
The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2011 to 2050. Am J Ophthalmol (2012) 1.06
Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence (2008) 1.00
Distribution of COL8A2 and COL8A1 gene variants in Caucasian primary open angle glaucoma patients with thin central corneal thickness. Mol Vis (2010) 0.98
Optic disk size variability between African, Asian, white, Hispanic, and Filipino Americans using Heidelberg retinal tomography. J Glaucoma (2009) 0.94
Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol (2015) 0.93
Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study. PLoS One (2013) 0.92
Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle Glaucoma. BMC Ophthalmol (2012) 0.91
An Updated Review on the Genetics of Primary Open Angle Glaucoma. Int J Mol Sci (2015) 0.90
Glaucoma medication adherence among African Americans: program development. Optom Vis Sci (2013) 0.90
Copy number variation at chromosome 5q21.2 is associated with intraocular pressure. Invest Ophthalmol Vis Sci (2013) 0.78
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
The Philadelphia Glaucoma Detection and Treatment Project: Detection Rates and Initial Management. Ophthalmology (2016) 0.77
Vascular considerations in glaucoma patients of African and European descent. Acta Ophthalmol (2014) 0.76
Seven-year incidence of uncorrected refractive error among an elderly Chinese population in Shihpai, Taiwan: The Shihpai Eye Study. Eye (Lond) (2016) 0.75
A retrospective study of the association between Fuchs' endothelial dystrophy and glaucoma. Clin Ophthalmol (2014) 0.75
Anti-glaucoma potential of Heliotropium indicum Linn in experimentally-induced glaucoma. Eye Vis (Lond) (2015) 0.75
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Mass treatment with single-dose azithromycin for trachoma. N Engl J Med (2004) 5.30
Strategies for control of trachoma: observational study with quantitative PCR. Lancet (2003) 3.40
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04
Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention. J Am Geriatr Soc (2002) 2.85
Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet (2006) 2.65
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet (2005) 2.50
Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology (2002) 2.45
How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation. Arch Ophthalmol (2002) 2.36
Driving status and risk of entry into long-term care in older adults. Am J Public Health (2006) 2.32
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci (2003) 2.20
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology (2008) 2.10
Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 2.05
Impact of presbyopia on quality of life in a rural African setting. Ophthalmology (2006) 2.00
Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology (2007) 2.00
Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology (2006) 1.96
Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci (2005) 1.94
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.86
Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial. PLoS Negl Trop Dis (2010) 1.81
Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol (2003) 1.80
Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology (2011) 1.74
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology (2009) 1.74
Population-based study of presbyopia in rural Tanzania. Ophthalmology (2006) 1.72
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol (2006) 1.64
Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci (2005) 1.62
Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology (2011) 1.58
A prospective, population-based study of the role of visual impairment in motor vehicle crashes among older drivers: the SEE study. Invest Ophthalmol Vis Sci (2007) 1.58
Estimating household and community transmission of ocular Chlamydia trachomatis. PLoS Negl Trop Dis (2009) 1.52
Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology (2007) 1.51
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology (2009) 1.47
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology (2009) 1.46
Impact of dry eye on reading in a population-based sample of the elderly: the Salisbury Eye Evaluation. Br J Ophthalmol (2013) 1.45
Definitions and standardization of a new grading scheme for eyelid contour abnormalities after trichiasis surgery. PLoS Negl Trop Dis (2012) 1.44
Causal inference for non-mortality outcomes in the presence of death. Biostatistics (2006) 1.42
CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis (2012) 1.40
Measures of visual function and their association with driving modification in older adults. Invest Ophthalmol Vis Sci (2006) 1.40
Measures of visual function and time to driving cessation in older adults. Optom Vis Sci (2005) 1.38
Comparison of limbus-based and fornix-based trabeculectomy: success, bleb-related complications, and bleb morphology. Ophthalmology (2012) 1.36
The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epidemiol (2015) 1.36
Iris cross-sectional area decreases with pupil dilation and its dynamic behavior is a risk factor in angle closure. J Glaucoma (2009) 1.35
Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology (2007) 1.35
Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. PLoS Negl Trop Dis (2012) 1.33
Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 1.31
Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerg Infect Dis (2004) 1.29
Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol (2008) 1.25
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci (2006) 1.24
Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis (2009) 1.23
Development of a new platform for neglected tropical disease surveillance. Int J Parasitol (2012) 1.23
Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol (2009) 1.21
Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology. Ophthalmic Epidemiol (2005) 1.19
Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology (2002) 1.19
Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci (2011) 1.18
Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. PLoS Negl Trop Dis (2011) 1.18
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol (2003) 1.18
Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol (2008) 1.17
Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Arch Ophthalmol (2005) 1.16
Cognitive and vision loss affects the topography of the attentional visual field. Invest Ophthalmol Vis Sci (2008) 1.16
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis (2013) 1.14
Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci (2005) 1.13
Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat (2006) 1.12
The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology (2010) 1.11
Heritability of refractive error and familial aggregation of myopia in an elderly American population. Invest Ophthalmol Vis Sci (2005) 1.10
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis (2003) 1.09
Relationship between immediate post-operative appearance and 6-week operative outcome in trichiasis surgery. PLoS Negl Trop Dis (2012) 1.09
Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology (2011) 1.08
Determinants and heritability of intraocular pressure and cup-to-disc ratio in a defined older population. Ophthalmology (2005) 1.08
Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg (2012) 1.08
Pattern of recurrence of trachomatous trichiasis after surgery surgical technique as an explanation. Ophthalmology (2005) 1.08
Glaucoma screening in the real world. Ophthalmology (2010) 1.08
Presbyopia: prevalence, impact, and interventions. Community Eye Health (2007) 1.07
Issues in defining and measuring facial cleanliness for national trachoma control programs. Trans R Soc Trop Med Hyg (2008) 1.07
The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology (2013) 1.07
Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. Arch Ophthalmol (2004) 1.07
Visual field loss increases the risk of falls in older adults: the Salisbury eye evaluation. Invest Ophthalmol Vis Sci (2007) 1.06
The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol (2006) 1.06
Visual and cognitive deficits predict stopping or restricting driving: the Salisbury Eye Evaluation Driving Study (SEEDS). Invest Ophthalmol Vis Sci (2008) 1.04
A randomized trial of visual impairment interventions for nursing home residents: study design, baseline characteristics and visual loss. Ophthalmic Epidemiol (2003) 1.04
Rates and risk factors for unfavorable outcomes 6 weeks after trichiasis surgery. Invest Ophthalmol Vis Sci (2011) 1.03
Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Ophthalmology (2008) 1.02
Mass treatment with azithromycin for trachoma control: participation clusters in households. PLoS Negl Trop Dis (2010) 1.02
Divided visual attention as a predictor of bumping while walking: the Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci (2004) 1.02